Reference (Year 2009)
This page introduces published papers regarding Carna's products and services contributed by our enployees. Ownership of copyright in papers is belonged to the the publisher or the third party holding the rights.
|Title||CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.|
|Author/s||Chikaraishi Y, Shimazawa M, Yokota K, Yoshino K, Hara H.|
|Name of Journal||Currrent Neurovascular Research|
|Published Date||August 2009|
|Volume||VOL. 6, Issue 3|